Abstract:Objective: To study the application of individualized selection of ventricular septal defect (VSD) occluder in interventional treatment and its efficacy and complications. Methods: One hundred and thirty-seven VSD patients, male 71 cases, female 66 cases, aged 3 to 76 (mean 31.52±16.13) years were enrolled, including perimembraneous VSD (98 cases), muscular VSD (10 cases), intracristal VSD (12 cases), residual shunt after surgical repair of VSD (11 patients), ventricular septal perforation after myocardial infarction (5 cases), and ventricular septal muscular rupture caused by trauma (1 case). Different occluders were selected according to the shape, the size of VSD and the relationship with the aortic and tricuspid valves. The efficacy, complications, size of chambers of heart and pulmonary artery pressure were assessed at 24 hours, 1 month, 3 months and 6 months respectively after procedures. Results: Among 137 cases, 124 were successfully proceed (90.51%) and 126 occluders were used during the procedures with two occluders placed in 2 patients respectively. The occluders were symmetric (26, 20.6%), edge 3 type (18, 14.3%), edge type 4 (44, 34.9%), edge type 5 (13, 10.3%), decentered (14, 11.1%) and muscular (11, 8.7%). Arrhythmia occurred after operation in 29 cases included degree 1 atrioventricular block (AVB), left anterior hemiblock (LAH), complete left bundle branch block (CLBBB), and incomplete right bundle branch block (IRBBB), complete right bundle branch block (CRBBB), supraventricular tarrhythmias. The recovery rate was 96.6%. There was no III-AVB happened. The anteroposterior diameter of the left atrium (LADap) and left ventricular end-diastolic diameter (LVDd) decreased significantly (P=0.001 and 0.002) 24 hours after the procedures. The left ventricular end-systolic diameter (LVDs) decreased but change was not statistically significant (P=0.097) 24 hours after the procedures. The LVDs continued to decrease significantly 1 month after procedures (P=0.007). The left ventricular ejection fraction (LVEF) showed no significant difference in pre-process, post-process and follow-up after procedures. The pulmonary artery systolic pressure (PASP) 24 hours after procedures decreased significantly (P=0.001) compared with that before, but there was no further decline 1 month after the procedures (P=0.820). Conclusions: The occluder of the treatment of transcatheter closure of VSD should be chosen individually according to different types of VSD. Thus, we can not only close VSD effectively, but also reduce or avoid the occurrence of iatrogenic complications.

Surgical Treatment of Large Muscular Ventricular Septal Defect In Adults

Clinical Analysis of Surgical Treatment for 189 Infants with Ventricular Septal Defect

Surgical Treatment of Muscular Ventricular Septal Defect in Infants with Multiple Ventricular Septal Defects

Perimembranous Ventricular Septal Defect Closure Via Ultra-Minimal Trans Intercostal Incision in Children.

Pathologic anatomy and surgical treatment of muscular ventricular septal defect

[Transesophageal Echocardiography-Guided Hybrid Therapy for Ventricular Septal Defects in Children].

Hybrid Approaches under Direct Vision for the Management of Muscular Ventricular Septal Defects

A Minimally Invasive Technique for Occluding Large Muscular Ventricular Septal Defects in Infants

[Surgical Treatment for Ventricular Septal Defect in Infants under 5 Kg of Body Weight].

Clinical analysis of surgical treatment of congenital atrioventricular septal defect

Is left ventriculotomy feasible for muscular ventricular septal defects in infants?

Pathologic Anatomy and Surgical Treatment of Conoventricular Septal Defect

Intraoperative closure of infant multiple muscular ventricular septal defects with Amplatzer occluder

Surgical Treatment of Tetralogy of Fallot with Subarterial Ventricular Septal Defect

Surgical Treatment of Complete Atrioventricular Septal Defect

Hybrid approaches for the treatment of muscular ventricular septal defects associated with additional congenital heart diseases

Surgical Treatment of Ventricular Septal Defects with Moderate or Severe Pulmonary Hypertension: A Report of 108 Cases

Surgical managements and their indications of double-outlet right ventricle with non-committed ventricular septal defect

Individualized selection of occluder in interventional treatment of ventricular septal defect (VSD)

Surgical Repair of Ventricular Septal Defect in 2085 Pediatric Patients

Percutaneous Closure of Postinfarct Muscular Ventricular Septal Defects: A Multicenter Study in China